Smoltek (SMOL) Q4 2025 earnings summary

Executive summary

• Transitioned from a research-driven startup to a supplier of application-specific innovations for global semiconductor and energy sectors.

• Focused on commercializing nanotechnology for capacitors and hydrogen applications, with strategic partnerships and infrastructure investments.

• Achieved key milestones in both semiconductor (capacitor production) and hydrogen (electrode development) segments.

Financial highlights

• Net sales for 2025 were 876 KSEK, down from 1,881 KSEK year-over-year; Q4 sales were 560 KSEK (0 previous year).

• Full-year net loss was -36,088 KSEK, compared to -33,399 KSEK in 2024; Q4 net loss was -8,048 KSEK (-10,224 KSEK prior year).

• EPS for 2025 improved to -0.28 SEK from -0.67 SEK; Q4 EPS was -0.04 SEK (-0.13 SEK prior year).

• Cash and cash equivalents at year-end were 6,397 KSEK.

• Equity at year-end was 73,623 KSEK, with a solidity of 75.1%.

Outlook and guidance

• Significant progress in commercialization of capacitor and hydrogen electrode technologies.

• Ongoing dialogues with global industry players and initial production capacity established for capacitors.

• Focus on further strengthening commercialization, business development, and project management.